US$ 24.30
tirzepatide taken off shortage list Compounders protest as FDA removes FDA says shortage of GLP-1
Description
If you are on semaglutide 1.0 mg, increasing to 1.7 mg or 2.4 mg may reignite weight loss without any medication switch

It is a 503A compounding pharmacy, which means every prescription is mixed patient by patient, to order, based on a prescriber directive

Patients should understand that non-scale victories often prove more meaningful than numbers alone

For tirzepatide, compounding became widely discussed during GLP-1 shortages because demand for Mounjaro and Zepbound outpaced supply
